Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

48 results about "Platinum Compound" patented technology

A chemotherapy compound that contains a platinum atom. Platinum compounds do not contain alkyl groups but do cause DNA crosslinks and adducts similar to alkylating agents. DNA crosslinks and adducts ultimately lead to the induction of apoptosis.

Method for testing platinum content in platinum compound solution

The invention discloses a method for testing the content of platinum in a platinum compound solution, and belongs to the technical field of analytical testing. According to the test method, an ammonium chloride precipitation gravimetric method is replaced by a hydrogen reduction gravimetric method, platinum ions in a platinum compound solution are reduced into elemental platinum in a hydrogen reduction mode, and the content of platinum in the solution is calculated by weighing the weight of a reduced platinum sinter and subtracting the content of impurity elements in the platinum sinter at the same time. According to the method, the platinum content in the platinum compound solution can be accurately and quantitatively analyzed, the operation process is simple, good repeatability is achieved, the range of multiple analysis results of the same sample is smaller than or equal to 0.05% and is far lower than the repeatability limit 0.2% of a national standard method, the analysis accuracy is guaranteed, and meanwhile the analysis efficiency is greatly improved.
Owner:CHENGDU GUANGMING PAITE PRECIOUS METAL CO LTD

Synthesis and fluorescence application of platinum compound with precise structure

The invention discloses synthesis and fluorescence application of a platinum compound with a precise structure, and belongs to the technical field of supramolecular fluorescent materials. The chemical composition of the supramolecule containing the phosphine ligand is Pt1C48H61P2Cl, the supramolecule containing the phosphine ligand is composed of a platinum metal atom, two 2-(dicyclohexylphosphino) biphenyl ligands and a chlorine ligand, and the platinum metal atom is coordinated with P atoms, Cl atoms, C atoms and P atoms respectively; the supramolecule containing the phosphine ligand belongs to a triclinic system, the space group is P-1, the cell parameters are # imgabs 0 # alpha = 85.242 degrees, beta = 81.586 degrees, gamma = 89.594 degrees and # imgabs 1 #, a solid sample of the ordered supramolecular compound prepared by the method provided by the invention exists stably, the ordered supramolecular compound has high thermal stability and good fluorescence quantum yield, the yield can reach 80% or above, the preparation method is simple, the cost is low, and the preparation method is suitable for industrial production. The method is suitable for preparing fluorescent materials and devices.
Owner:BEIJING UNIV OF CHEM TECH

Quadrivalent platinum compound as well as preparation method and application thereof

The invention belongs to the technical field of medicine synthesis, and particularly relates to a tetravalent platinum compound as well as a preparation method and application thereof. The invention provides a tetravalent platinum compound. The tetravalent platinum compound has a structure shown as a formula a to a formula d, wherein linker is respectively connected with a Pt-containing mother nucleus and a PARP inhibitor through-O-C = O; the PARP inhibitor comprises a carboxyl-containing structure and a carboxyl-free structure; when the PARP inhibitor contains a carboxyl structure, the linker is when the PARP inhibitor does not contain the carboxyl structure, and the data of the linker as the embodiment shows that the tetravalent platinum compound provided by the invention has good anti-tumor activity and low tumor drug resistance when being used as the PARP inhibitor.
Owner:SHANDONG ACADEMY OF PHARMACEUTICAL SCIENCES

Platinum-based phosphorescent dopant materials, methods of preparation, and organic electroluminescent devices and applications

The application discloses a phosphorescent dopant material of a platinum compound, a preparation method, an organic electroluminescent device and application, the phosphorescent dopant material is a platinum compound with a structure shown in chemical formula I, the compound introduces a bicyclic structure on the basis of a parent nucleus, a high conjugated electron distribution system, so that the electron distribution and the excited state can be controlled, and the stability of the material is enhanced. The organic electroluminescent device prepared by adopting the compound as a light-emitting layer dopant material has high luminous efficiency, long service life and the technical effect of improving the driving voltage.
Owner:JILIN OPTICAL & ELECTRONICS MATERIALS CO LTD

Thermally conductive silicone composition

InactiveEP4488335A1Polymer scienceHigh humidity
The present invention is a thermal conductive silicone composition including: (A) an organopolysiloxane having at least two alkenyl groups per molecule: 100 parts by mass; (B) an organohydrogen polysiloxane having at least two silicon atom-bonded hydrogen atoms per molecule: in an amount such that (the number of Si-H groups in the component (B)) / (the number of alkenyl groups in the component (A)) is 0.5 to 3.0; (C) a filler containing one or more thermal conductive powders: 800 to 20,000 parts by mass; (D) a hydrolyzable organopolysiloxane of formula (1): 20 to 400 parts by mass; (E) an organosilane shown by formula (2), R2bSi(OR3)4-b: 0.01 to 100 parts by mass; (F) platinum or a platinum compound: 0.1 to 500 ppm as platinum atoms relative to the component (A); and (G) a reaction regulator: 0.01 to 1 parts by mass. This provides a thermal conductive silicone composition with high thermal conductivity that does deteriorate in thermal resistance even at high temperatures and high humidity, does not experience an increase in elastic modulus even at high temperatures, and does not generate voids.
Owner:SHIN ETSU CHEMICAL CO LTD

Platinum complexes and devices

To provide platinum compounds that can be useful as emitters in display and lighting applications.SOLUTION: Platinum compounds of Formulas I and II useful in a variety of devices, such as, for example organic-light emitting diodes (OLEDs).SELECTED DRAWING: Figure 1
Owner:THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA +1

A derivative having a tetravalent platinum structure of desloratadine and its preparation method and use

The present invention provides a derivative having a desloratadine tetravalent platinum structure, a preparation method, and a use thereof. The compound having a desloratadine tetravalent platinum structure is shown in general formula (I), #imgabs0# wherein #imgabs1# is selected from cisplatin or oxaliplatin; L is hydroxyl or #imgabs2#. The desloratadine tetravalent platinum compound of the present invention has good anti-tumor proliferation activity and a good therapeutic effect on metastatic malignant tumors; it can effectively inhibit the tumor epithelial-mesenchymal transition (EMT) process and effectively activate tumor immune response, and can be used to prepare anti-tumor drugs, especially providing a new direction for the research and development of anti-metastatic malignant tumor drugs.
Owner:LIAOCHENG UNIV

Trimethylplatinum(IV) iodide

The invention relates to a method for producing trimethylplatinum(IV) iodide and trimethylplatinum(IV) iodide obtainable according to said method and the use thereof as a reactant for producing platinum(IV) compounds, as a precatalyst and as a catalyst. The platinum(IV) compounds thus obtainable, as well as the use thereof as precursors for the deposition of platinum layers and platinum-containing layers on a surface of a substrate are also the subject matter of the invention. The invention also relates to a substrate comprising a platinum layer or a platinum-containing layer on a surface, and to a method for producing an electronic component, in particular an electronic semiconductor component, or an electrode for a fuel cell using a platinum(IV) compound obtainable using trimethylplatinum(IV) iodide, which is obtainable by means of the method described herein.
Owner:UMICORE AG & CO KG

Trimethylplatinum(IV) iodide

The invention relates to a method for producing trimethylplatinum(IV) iodide and trimethylplatinum(IV) iodide obtainable according to said method and the use thereof as a reactant for producing platinum(IV) compounds, as a precatalyst and as a catalyst. The platinum(IV) compounds thus obtainable, as well as the use thereof as precursors for the deposition of platinum layers and platinum-containing layers on a surface of a substrate are also the subject matter of the invention. The invention also relates to a substrate comprising a platinum layer or a platinum-containing layer on a surface, and to a method for producing an electronic component, in particular an electronic semiconductor component, or an electrode for a fuel cell using a platinum(IV) compound obtainable using trimethylplatinum(IV) iodide, which is obtainable by means of the method described herein.
Owner:UMICORE AG & CO KG

Pegylated cis-platinum compound as well as preparation method and application thereof

The invention relates to a pegylated cis-platinum compound as well as a preparation method and application thereof, and belongs to the technical field of drug carriers. The pegylated cis-platinum compound is obtained through covalent coupling of polyethylene glycol and cis-platinum. The invention provides a novel pegylated cis-platinum compound and a preparation method thereof, a pharmaceutical composition containing the pegylated cis-platinum compound and a preparation of the pharmaceutical composition, and particularly relates to a nucleic acid pharmaceutical composition containing the pegylated cis-platinum compound and a preparation of the nucleic acid pharmaceutical composition. The nucleic acid medicine composition preparation can deliver the nucleic acid medicine into cells, the transport rate of the nucleic acid medicine is increased, toxicity is reduced, and therefore the treatment effect of the nucleic acid medicine is improved.
Owner:BEIJING HEMU BIOTECHNOLOGY CO LTD

Drug-induced renal dysfunction relieving agent

To provide a drug-induced renal dysfunction relieving agent that enables inhibition or mitigation of renal dysfunction resulting from administration of a drug.SOLUTION: A drug-induced renal dysfunction relieving agent comprising, as an active ingredient, a dopamine D2-like receptor agonist. The dopamine D2-like receptor may be DRD2. The dopamine D2-like receptor agonist may be at least one selected from the group consisting of quinpirole, dopamine, ropinirole, and bromocriptine. The agent is preferably administered to a patient having drug-induced renal dysfunction caused by administration of a platinum-based anticancer agent, an antibacterial agent, an antiviral agent, a contrast medium, or an NSAIDs.SELECTED DRAWING: None
Owner:NATIONAL UNIVERSITY CORPORATION OITA UNIVERSITY

Composite high-temperature insulating material as well as preparation method and application thereof

The invention provides a composite high-temperature insulating material as well as a preparation method and application thereof. The composite high-temperature insulating material comprises a silica gel composite material and a mica paper composite material; wherein the raw materials of the silica gel composite material comprise the following components in parts by weight: 100 parts of raw silicone rubber; 1-50 parts by weight of silicone resin; 0-15 parts by weight of a structured control agent; 1-60 parts by weight of a reinforcing system; 10-150 parts by weight of a main flame retardant system; 5-100 parts by weight of a synergistic flame retardant system; 5-150 parts by weight of an inorganic filling system; 0-300 parts by weight of an organic solvent; the synergistic auxiliary agent comprises 1-200ppm of a platinum compound or a complex based on the platinum content; 1-10 parts by weight of a curing agent system; 0-1 part by weight of a curing inhibitor system; and 0.1-10 parts by weight of a color matching system. In a special system, the silica gel composite material is compounded with the mica paper composite material by adopting a set process through the formula design of the silica gel composite material, so that the flame retardant property is excellent, and meanwhile, the requirements that the high-temperature sintering non-cracking shape is kept well and the crusting property is complete are met, so that the flame-retardant, fireproof and fire-resistant requirements are met.
Owner:SHANGHAI KETER POLYMER MATERIAL +1

Platinum compound and use thereof

The present invention provides a compound of formula (I), or a pharmaceutically acceptable salt, isotope variant, tautomer, stereoisomer, prodrug, polymorph, hydrate, or solvate thereof, and a pharmaceutical composition comprising same and a use thereof as a radiosensitizing drug.
Owner:JIANGSU SYNTHGENE BIOTECHNOLOGY CO LTD

Thermal conductive silicone composition

PendingUS20250129216A1Polymer sciencePolymer chemistry
A thermal conductive silicone composition including: (A) an organopolysiloxane having at least two alkenyl groups per molecule: 100 parts by mass; (B) an organohydrogen polysiloxane having at least two silicon atom-bonded hydrogen atoms per molecule: such that (the number of Si—H groups in component (B)) / (the number of alkenyl groups in component (A)) is 0.5 to 3.0; (C) a filler containing one or more thermal conductive powders: 800 to 20,000 parts by mass; (D) a hydrolyzable organopolysiloxane of formula (1): 20 to 400 parts by mass; (E) an organosilane of formula (2), R2bSi(OR3)4-b: 0.01 to 100 parts by mass; (F) platinum or a platinum compound: 0.1 to 500 ppm as platinum atoms relative to component (A); and (G) a reaction regulator: 0.01 to 1 parts by mass.
Owner:SHIN ETSU CHEMICAL CO LTD

Polygonal anthracene functionalized BODIPY supramolecular metal ring compound as well as preparation method and application thereof

The invention discloses a polygonal anthracene functionalized BODIPY supramolecular metal ring compound as well as a preparation method and application thereof, and belongs to the technical field of supramolecular materials, the polygonal anthracene functionalized BODIPY supramolecular metal ring compound is obtained by self-assembly reaction of an anthracene functionalized BODIPY photosensitizer with a specific structure and a platinum compound; by selecting platinum compounds with different coordination included angles, triangular, quadrilateral and hexagonal supramolecular metal ring compounds are respectively prepared. Furthermore, amphiphilic polymer F127 is used for wrapping the supramolecular metal ring compound to form water-soluble nanoparticles, so that phototherapy and chemotherapy combined therapy of hypoxic tumors can be realized, and the amphiphilic polymer F127 has a wide application prospect in the aspects of biological imaging and tumor therapy.
Owner:HANGZHOU NORMAL UNIVERSITY

10-hydroxybenzoquinoline platinum complex as well as synthesis method and application thereof

The invention provides a 10-hydroxybenzoquinoline platinum complex as well as a synthesis method and application thereof, and belongs to the technical field of medicines, and the chemical formula of the 10-hydroxybenzoquinoline platinum complex is C15H15ClNO2 PtS. The platinum compound L-Pt shows a remarkable inhibition effect on MDA-MB-231 cancer cells, and the IC50 value of the platinum compound L-Pt is 0.092 + / -0.01 [mu] M and is far lower than that of a clinical anti-tumor drug cis-platinum (8.86 + / -0.79 [mu] M); compared with the prior art, synthesis raw material ligands L and cis-Pt (DMSO) 2Cl2 of the platinum compound L-Pt almost have no inhibition effect on MDA-MB-231 cancer cells, the platinum compound L-Pt has high tumor selectivity on the MDA-MB-231 cancer cells, the 10-hydroxybenzoquinoline platinum compound L-Pt shows excellent anti-tumor activity, the potential value of the 10-hydroxybenzoquinoline platinum compound L-Pt as medicine development is shown, and the application prospect is broad. And the compound is expected to become a candidate substance for preparing various anti-tumor drugs.
Owner:BAISE UNIV

A nano-drug of grapefruit extracellular vesicle loaded with trifunctional tetravalent platinum compound and preparation method and application thereof

The application provides a trifunctional tetravalent platinum compound of captopril-aspirin ligand and a reference drug of a bifunctional tetravalent platinum compound of captopril; and develops a nanomedicine Tf-GEVs@Pt(IV) of the aspirin-captopril trifunctional tetravalent platinum compound loaded in grapefruit extracellular vesicles (GEVs). The Tf-GEVs@Pt(IV) is prepared from the trifunctional tetravalent platinum compound as an active ingredient, the carrier grapefruit extracellular vesicles (GEVs), the carrier DSPE-PEG and the transferrin modified targeting carrier DSPE-PEG-Tf. The Tf-GEVs@Pt(IV) can release the active component trifunctional tetravalent platinum compound in vivo. In addition to causing DNA damage, the trifunctional tetravalent platinum compound as the active component of the nanomedicine can effectively regulate inflammatory, fibrotic and immunosuppressive TME. The nanomedicine has a significant anti-tumor ability and has excellent therapeutic effect on metastatic malignant tumors, and is expected to provide a new candidate drug for clinical treatment of tumors and provide a new direction for research and development of new platinum drugs and anti-metastatic malignant tumor drugs.
Owner:LIAOCHENG UNIV

Platinum (II) compounds and their derivatives with targeting effects, preparation methods, pharmaceutical compositions and uses

The present invention discloses a class of platinum(II) compounds with targeting effects, their derivatives, preparation methods, pharmaceutical compositions and applications. The structure of this class of platinum(II) compounds is as follows: The derivatives of this class of platinum(II) compounds refer to isomers of the platinum(II) compounds or mixtures thereof. This class of platinum(II) compounds and their derivatives have active targeting effects, can specifically inhibit related protein kinases and cancer cells. At the same time, the chemical structure contains a C=N double bond, which can passively target tumors using the acidic microenvironment of tumors and reduce tissue toxicity. They exhibit the characteristics of high efficiency and low toxicity in anti-tumor, and can overcome the drug resistance problems of existing platinum-based and targeted drugs. In addition, the synthesis method of this class of platinum(II) compounds is simple and easy to implement.
Owner:SOUTHEAST UNIV

Trans-platinum as well as preparation method and application thereof

The invention relates to the field of biological medicine, in particular to trans-platinum and a preparation method and application thereof. The invention provides trans-platinum. The trans-platinum has a structure as shown in a formula I, # imgabs0 # is shown as a formula I; wherein R1 to R5 are independently selected from hydrogen, halogen, CHO, OH, NH2 or CH3. The trans-platinum provided by the invention is a divalent platinum compound with pyroptosis induction capability, has a trans structure, and comprises two chlorine ligands at the trans position, an ammonia ligand at the trans position and a nitrogen-containing heterocyclic ring ligand at the trans position, and the nitrogen-containing heterocyclic ring ligand is designed to be pyridine or a derivative ligand thereof. Due to the existence of a trans structure and a planar ligand, a DNA cross-linking mode different from classical platinum drugs such as cis-platinum is adopted, and the compound has pyroptosis induction capacity, can induce tumor cell immunogenic death and activate anti-tumor immune response, and has a cancer cell killing mode different from that of cis-platinum and excellent cancer cell killing capacity as a platinum drug.
Owner:CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY CHINESE ACADEMY OF SCIENCES

A platinum compound for treating cancer and its preparation method

The present invention discloses a novel platinum compound represented by formula (I), and their use as a medicament, especially a medicament for treating cancer alone or in combination, and preventing cancer. Experiments have shown that the novel platinum compound of the present invention has a superior in vivo anti-tumor effect, which is significantly better than the clinical drug carboplatin; and the water solubility of the platinum drug is significantly improved, and it can be made into a lyophilized powder or an injection, solving the defect of inconvenient clinical use. In summary, the platinum compound disclosed in the present invention has a good prospect for clinical application.
Owner:SHANGHAI HAIJU BIOLOGICAL TECH CO LTD

Flame-retardant silicone rubber and method for producing the same

PendingCN122326002APolymer scienceVulcanization
This invention belongs to the field of silicone rubber technology and relates to a flame-retardant compounded silicone rubber and its preparation method. The invention involves first adding methyl vinyl silicone rubber raw material, precipitated silica, hydroxyl silicone oil, zinc stearate, silane coupling agent, and composite flame-retardant filler to a kneader for kneading. After kneading, heat treatment, and cooling, compound A is obtained. Then, compound A is mixed evenly with a platinum-containing flame-retardant additive in a specific ratio on a two-roll mill to obtain the flame-retardant compounded silicone rubber. The platinum-containing flame-retardant additive is a compound of platinum compound and vinyl amino silicone oil at a mass ratio of 1:0.5~1. This method is simple, and the prepared compounded silicone rubber has high flame-retardant properties. It utilizes a combination of platinum compound, nitrogen-containing organic compound, and composite flame-retardant filler, resulting in a strong synergistic flame-retardant effect. It also offers advantages such as good roller workability, high processing efficiency, and minimal yellowing of vulcanized samples, making it easy to promote and apply.
Owner:江西晨光新材料股份有限公司

Platinum complexes and devices

Platinum compounds of Formulas I and II useful in a variety of devices, such as, for example organic-light emitting diodes (OLEDs).
Owner:THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA

High-thermal-conductivity flame-retardant organic silicon pouring sealant for power battery module as well as preparation method and application of high-thermal-conductivity flame-retardant organic silicon pouring sealant

The invention discloses a high-thermal-conductivity flame-retardant organic silicon pouring sealant for a power battery module as well as a preparation method and application of the high-thermal-conductivity flame-retardant organic silicon pouring sealant. The pouring sealant is composed of a component A and a component B, wherein the component A contains vinyl-terminated polysiloxane, a composite heat-conducting filler, a synergistic flame retardant, a cross-linking agent and an inhibitor; and the component B contains vinyl-terminated polysiloxane, a composite heat-conducting filler, a synergistic flame retardant and a platinum catalyst. The composite heat-conducting filler is prepared from modified spherical aluminum oxide and flaky boron nitride according to a specific proportion, and the synergistic flame retardant is prepared by compounding encapsulated red phosphorus and a platinum compound. The component A and the component B are mixed according to the ratio of 1: 1 and then cured to form the elastomer with high thermal conductivity (greater than or equal to 2.0 W / m.K), high flame retardance (UL94 V-0), low stress and high reliability. The pouring sealant disclosed by the invention is particularly suitable for a power battery module needing efficient heat management and extreme safety.
Owner:BEIJING COMENS NEW MATERIALS

Glycyrrhetinic acid-platinum compound as well as preparation method and application thereof

The invention provides a glycyrrhetinic acid-platinum compound as shown in a structural formula as well as a preparation method and application thereof, and belongs to the technical field of medicines. The preparation method comprises the following steps: taking glycyrrhetinic acid as a raw material, coupling the glycyrrhetinic acid with dimethyl 3-amino-1, 1-cyclobutanedicarboxylate through an amido bond, converting the glycyrrhetinic acid into a sodium salt, and carrying out coordination substitution reaction on the sodium salt and a hydrate cis-[PtA2 (H2O) 2] (NO3) 2 of a platinum drug on the market to prepare a compound 1; the compound provided by the invention has inhibitory activity on human hepatoma cell lines HepG2, Huh7 and SK-Hep-1, can form a pharmaceutical composition with a pharmaceutically acceptable carrier, and can be used for preparing anti-hepatoma drugs.
Owner:KUNMING INST OF BOTANY CHINESE ACAD OF SCI +1

Method for synergistically and co-extracting platinum and iridium by using composite extracting agent

The invention belongs to the technical field of synergistic extraction, and particularly relates to a method for synergistically and co-extracting platinum and iridium by using a composite extracting agent. According to the method, an amino-containing extraction agent and a phosphorus-containing extraction agent are innovatively compounded to obtain the synergistic extraction agent, and the volume ratio of the amino-containing extraction agent in an organic phase is controlled to be 1-62%, and the volume ratio of the phosphorus-containing extraction agent in the organic phase is controlled to be 1-62%. According to the method, two extractants are used for extracting platinum and iridium, so that the two extractants play a synergistic role to the greatest extent, then the synergistic extractant is used for extracting a solution containing platinum and iridium, finally, the platinum and the iridium are separated from the extractants through reverse extraction, and finally a mixture only containing a platinum compound and an iridium compound is obtained. The platinum and the iridium in the mixture can be subsequently separated according to needs. By adopting the method disclosed by the invention, platinum and iridium can be effectively recovered from a mixture of various substances, and the recovery rate of platinum and iridium is greater than 99.5%.
Owner:JINCHUAN GROUP CO LTD +1

Thermally conductive silicone composition

The present invention provides a thermally conductive silicone composition comprising: (A) 100 parts by mass of an organopolysiloxane having at least two alkenyl groups in one molecule; (B) an organohydrogenpolysiloxane having, in one molecule, at least two hydrogen atoms bonded to a silicon atom, wherein the ratio of the number of Si-H groups in the component (B) to the number of alkenyl groups in the component (A) is 0.5-3.0; (C) 800-20,000 parts by mass of a filler containing one or more types of thermally conductive powder; (D) 20-400 parts by mass of a hydrolyzable organopolysiloxane of formula (1); (E) 0.01 to 100 parts by mass of an organosilane represented by formula (2): R2bSi (OR3) 4-b; (F) platinum or a platinum compound, wherein the platinum atoms are 0.1-500 ppm of component (A); and (G) 0.01-1 part by mass of a reaction control agent. As a result, a thermally conductive silicone composition which does not deteriorate in thermal resistance even at high temperatures and high humidity, does not undergo high modulus of elasticity even at high temperatures, does not produce voids, and has a high thermal conductivity is provided. # imgabs0 #
Owner:SHIN ETSU CHEMICAL CO LTD

Oxaprozin coupled cis-platinum compound as well as preparation method and application thereof

The invention belongs to the technical field of biological medicines, and discloses an oxaprozin coupled cis-platinum compound as well as a preparation method and application thereof. The oxaprozin coupled cis-platinum compound disclosed by the invention is tetravalent platinum prepared by coupling cis-platinum and oxaprozin which is a drug with carboxyl; the oxaprozin coupled cis-platinum compound disclosed by the invention can improve the toxic and side effects of cis-platinum and increase novel axial functional groups, and has the technical advantages of excellent anti-tumor activity, stability, safety and low cost.
Owner:CHINA PHARM UNIV

A type of tetravalent platinum complex containing APR-246 and its preparation method and application

The present invention discloses a tetravalent platinum complex containing APR-246, having a structure as shown in Formula I: wherein n is selected from 0, 1, 2, 3, or 4; R is selected from a branched or linear C1-C20 alkyl group; and R2 is selected from a branched or linear C1-C20 alkyl group. The tetravalent platinum compounds containing the p53 mutation activator APR-246 provided by the present invention can enhance the anti-tumor activity of APR-246 and leverage the anti-tumor advantages of APR-246 and divalent platinum drugs. By utilizing the unique anti-tumor mechanism of APR-246, they can work together with platinum drugs to achieve excellent synergistic anti-tumor efficacy, while also significantly helping to improve tumor drug resistance.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY